SCOPIA CAPITAL MANAGEMENT LP - Q4 2014 holdings

$5.37 Billion is the total value of SCOPIA CAPITAL MANAGEMENT LP's 30 reported holdings in Q4 2014. The portfolio turnover from Q3 2014 to Q4 2014 was 52.6% .

 Value Shares↓ Weighting
SPR BuySPIRIT AEROSYSTEMS HLDGS INC$949,013,000
+18.5%
22,049,547
+4.8%
17.68%
+8.2%
IWM BuyISHARES TRput$585,851,000
+78.3%
4,897,600
+63.0%
10.91%
+62.9%
SPY SellSPDR S&P 500 ETF TRput$582,398,000
-12.0%
2,833,500
-15.6%
10.85%
-19.6%
UTHR BuyUNITED THERAPEUTICS CORP DEL$382,965,000
+13.0%
2,957,490
+12.3%
7.13%
+3.2%
BIDU BuyBAIDU INCspon adr rep a$329,469,000
+16.5%
1,445,230
+11.5%
6.14%
+6.4%
INFA BuyINFORMATICA CORP$246,314,000
+19.7%
6,458,993
+7.5%
4.59%
+9.3%
ALR BuyALERE INC$205,359,000
+28.3%
5,404,190
+30.9%
3.82%
+17.2%
FCEA BuyFOREST CITY ENTERPRISES INCcl a$201,841,000
+27.2%
9,476,120
+16.8%
3.76%
+16.2%
TEVA BuyTEVA PHARMACEUTICAL INDS LTDadr$191,722,000
+33.2%
3,333,717
+24.5%
3.57%
+21.7%
MLNX BuyMELLANOX TECHNOLOGIES LTD$182,912,000
+4.3%
4,280,648
+9.5%
3.41%
-4.8%
TFM SellFRESH MKT INC$157,487,000
+0.6%
3,822,492
-14.7%
2.93%
-8.1%
DAR SellDARLING INGREDIENTS INC$146,992,000
-19.8%
8,094,286
-19.1%
2.74%
-26.7%
MYGN BuyMYRIAD GENETICS INC$142,237,000
+43.4%
4,176,074
+62.4%
2.65%
+31.0%
AN SellAUTONATION INC$139,018,000
+12.9%
2,301,239
-6.0%
2.59%
+3.2%
AEGR BuyAEGERION PHARMACEUTICALS INC$112,026,000
-33.2%
5,349,840
+6.5%
2.09%
-39.0%
BKD BuyBROOKDALE SR LIVING INC$110,640,000
+20.1%
3,017,172
+5.5%
2.06%
+9.7%
MSI BuyMOTOROLA SOLUTIONS INCput$100,627,000
+11.8%
1,500,100
+5.5%
1.87%
+2.1%
SALE BuyRETAILMENOT INC$98,227,000
+14.0%
6,718,642
+26.0%
1.83%
+4.2%
COH NewCOACH INCcall$93,021,0002,476,600
+100.0%
1.73%
BA SellBOEING COput$88,997,000
+1.7%
684,700
-0.3%
1.66%
-7.1%
INTC SellINTEL CORPput$74,028,000
-48.4%
2,039,900
-50.5%
1.38%
-52.9%
BCO NewBRINKS CO$70,283,0002,879,263
+100.0%
1.31%
XLE NewSELECT SECTOR SPDR TRsbi int-energy$48,132,000608,038
+100.0%
0.90%
USO NewUNITED STATES OIL FUND LPunits$36,543,0001,794,852
+100.0%
0.68%
PTLA NewPORTOLA PHARMACEUTICALS INC$29,199,0001,031,026
+100.0%
0.54%
TEVA SellTEVA PHARMACEUTICAL INDS LTDcall$23,165,000
-27.2%
402,800
-31.9%
0.43%
-33.4%
AROPQ BuyAEROPOSTALE$18,239,000
-28.7%
7,861,494
+1.2%
0.34%
-34.7%
ZSPH NewZS PHARMA INC$9,474,000227,902
+100.0%
0.18%
QLTI  QLT INC$8,710,000
-11.3%
2,172,0960.0%0.16%
-19.0%
PHH  PHH CORP$3,484,000
+7.2%
145,4000.0%0.06%
-1.5%
AMSC ExitAMERICAN SUPERCONDUCTOR CORP$0-219,367
-100.0%
-0.01%
TRN ExitTRINITY INDS INCput$0-14,200
-100.0%
-0.01%
DNDNQ ExitDENDREON CORP$0-1,824,183
-100.0%
-0.05%
OVTI ExitOMNIVISION TECHNOLOGIES INC$0-138,067
-100.0%
-0.07%
DMND ExitDIAMOND FOODS INC$0-129,006
-100.0%
-0.08%
PSEC ExitPROSPECT CAPITAL CORPORATIONput$0-750,000
-100.0%
-0.15%
SYF ExitSYNCHRONY FINL$0-350,000
-100.0%
-0.18%
GEO ExitGEO GROUP INC NEW$0-325,504
-100.0%
-0.25%
ADT ExitTHE ADT CORPORATION$0-584,353
-100.0%
-0.42%
EPI ExitWISDOMTREE TRput$0-1,400,000
-100.0%
-0.62%
ExitPHH CORPnote 6.000% 6/1$0-21,500,000
-100.0%
-0.84%
INTC ExitINTEL CORPcall$0-1,569,700
-100.0%
-1.11%
CLGX ExitCORELOGIC INC$0-2,810,018
-100.0%
-1.55%
GNRC ExitGENERAC HLDGS INCcall$0-2,111,800
-100.0%
-1.75%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2015-02-17
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
SPIRIT AEROSYSTEMS HLDGS INC39Q4 202228.3%
SPDR S&P 500 ETF TR31Q3 202316.9%
ISHARES TR28Q3 202310.9%
MANNKIND CORP24Q3 20230.5%
BAIDU INC21Q2 20188.6%
ITRON INC21Q3 202012.1%
RETROPHIN INC20Q3 20204.5%
HARMONIC INC19Q3 202310.5%
JOHNSON CTLS INTL PLC17Q3 20209.6%
ACORDA THERAPEUTICS INC17Q3 20194.0%

View SCOPIA CAPITAL MANAGEMENT LP's complete holdings history.

Latest significant ownerships (13-D/G)
SCOPIA CAPITAL MANAGEMENT LP Q4 2014 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
VERRA MOBILITY CorpOctober 28, 20226,710,0744.4%
Spirit AeroSystems Holdings, Inc.February 14, 20222,084,2122.0%
Retrophin, Inc.February 14, 20202,011,6974.7%
Horizon Therapeutics Public Ltd CoJanuary 10, 20202,527,4561.4%
ZOGENIX, INC.January 10, 2020919,4842.1%
ITRON, INC.January 07, 20201,808,0594.6%
ACORDA THERAPEUTICS INCSold outNovember 12, 201900.0%
LA JOLLA PHARMACEUTICAL COApril 10, 2019480,0001.8%
Prothena Corp plcMarch 11, 20191,883,8164.7%
GW PHARMACEUTICALS PLCFebruary 14, 20191,345,1984.6%

View SCOPIA CAPITAL MANAGEMENT LP's complete significant-ownership history.

Latest filings
TypeFiled
SC 13D2024-04-26
13F-HR2024-02-14
SC 13G2024-02-14
SC 13D/A2024-01-22
13F-HR/A2023-11-14
13F-HR2023-11-14
SC 13D2023-09-21
13F-HR2023-08-14
13F-HR2023-05-15
SC 13D/A2023-04-12

View SCOPIA CAPITAL MANAGEMENT LP's complete filings history.

Compare quarters

Export SCOPIA CAPITAL MANAGEMENT LP's holdings